Valmet Oyj VALMT.HE
Composite 53/100; the shares have moved about 40% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 34/100 — a moderate mark against it.
Income ranks 85/100 — a strong point in its favour. Valuation ranks 73/100 — a moderate point in its favour. Momentum ranks 60/100 — a slight point in its favour.
Growth ranks 34/100 — a moderate mark against it. Quality ranks 43/100 — a slight mark against it. Balance-sheet strength ranks 49/100 — a slight mark against it.
What the company does Valmet Oyj designs and delivers process technologies, automation, and lifecycle services for pulp, paper, packaging, tissue, and energy industries across EMEA, Asia-Pacific, and the Americas. Its two segments—Process Performance Solutions and Biomaterial Solutions and Services—offer flow control, automation systems, and full production lines with upgrades, rebuilds, and maintenance.
Key financials Valmet posts ROE 12%, ROA 5%, and ROCE 11.5%, with gross, operating, and net margins of 27%, 10%, and 6% respectively. Revenue grew 6% and EPS surged 167%, supported by strong cash flow (FCF yield 6%). Leverage is moderate (Debt/Equity 0.63; Net debt/EBITDA 1.42), and the dividend yield is 5.1% with a payout of 83%.
Stock health Momentum is mixed: +19% over 3 months but -12% over 12 months and -14% from the 52-week high, with RSI at 75 indicating overbought conditions. Quality metrics are average (Quality score 49), while Income is strong (score 81) and Valuation attractive (score 68).
Price vs fair value The stock trades at a **discount** of 17.84% versus the analyst 12-month target of 31.02. - Trading at a valuation percentile of 68 (Valuation score 68.3). - EV/EBITDA of 8.41 and P/E of 16.15 signal undemanding multiples. - High dividend yield 5.1% and FCF yield 5.8% support valuation. - Momentum overbought (RSI 75) may cap near-term upside.
Looking forward Analysts expect continued growth in automation and services, but macro demand in paper/pulp remains a watchpoint. Execution on margin expansion and cash flow conversion will be key to sustaining valuation support.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.